Today: 20 May 2026
OCBC stock price inches up as Citi-backed securities-lending launch keeps focus on Feb earnings
29 January 2026
1 min read

OCBC stock price inches up as Citi-backed securities-lending launch keeps focus on Feb earnings

Singapore, Jan 29, 2026, 14:51 SGT — Regular session

Shares of Oversea-Chinese Banking Corp (OCBC) in Singapore edged up 0.23% to S$21.34 by 2:39 p.m. local time on Thursday. The stock fluctuated between S$21.25 and S$21.37, with roughly 1.8 million shares traded.

Brokers have raised their target prices — estimates of where a stock could trade within the next year — following a strong run from Singapore’s big three banks that pushed the Straits Times Index to fresh highs. OCBC’s average target price, based on 17 analysts, climbed 3.1% last week to S$20.70, according to the Business Times, even as the stock hit S$21.42 on Tuesday. Meanwhile, consensus targets for DBS and UOB nudged up to S$59.78 and S$37.26 respectively.

On Thursday, Singapore’s central bank held its exchange-rate policy steady but signaled rising risks to growth and inflation. OCBC economist Selena Ling described the stance as “a tad more hawkish and less dovish,” while Maybank’s Chua Hak Bin said he felt “more positive on the growth outlook.” Reuters

OCBC launched a securities-lending programme on Wednesday through Citigroup’s Citi Securities Lending Access platform. The move allows brokerage customers to lend out U.S. and Hong Kong shares for fees, while still collecting dividends and retaining selling rights, the bank said. OCBC aims to roll out the service to Bank of Singapore clients by 2026, covering Singapore and Japan shares. It referenced S&P Global Market Intelligence data showing securities-lending revenues hit $1.2 billion in December 2025. “Securities lending brings benefits such as higher trading volumes, price discovery and market efficiency,” said Kenneth Lai, OCBC’s head of global markets. Citi’s Mridula Iyer added the partnership would expand access to a wider range of market participants. OCBC

RHB raised its target price for OCBC to S$21.30 from S$18.70 but maintained a “neutral” rating, the Business Times reported. The bank expects single-digit year-on-year earnings growth in OCBC’s upcoming results. RHB also forecasts a final dividend of S$0.575 per share and a full-year payout of S$0.985, which it estimates will represent a 60% dividend payout. The Business Times

Securities lending lets investors loan out shares to institutional borrowers, usually for short-selling or hedging, in exchange for a fee. For banks, it’s more of a market-services play than a traditional lending risk. Demand can be uneven, often tracking trading volumes.

But the rally in bank shares has narrowed the margin for error. A quicker-than-anticipated drop in interest rates could pinch net interest margins, while a rise in credit costs would challenge investors’ faith in the sector’s dividend appeal.

OCBC is set to release its full-year 2025 financial results on Feb. 25, ahead of market open, according to an SGX filing. Investors will focus on margin trends, loan growth, and capital returns amid the recent rally in bank shares.

Stock Market Today

  • Oil Prices Fall After Trump Comments on Ending Iran War
    May 20, 2026, 7:14 AM EDT. Oil prices declined on Tuesday following President Trump's statement reaffirming his intent to end the conflict with Iran "very quickly." The Strait of Hormuz, a critical chokepoint for global oil shipments, experienced one of its busiest days since its recent closure, underscoring the region's importance to energy markets and the potential impact of geopolitical developments on supply dynamics.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 29.01.2026

iFAST share price slides 2.6% after Tembusu-linked stake trim; Feb 12 results in focus
Next Story

iFAST share price slides 2.6% after Tembusu-linked stake trim; Feb 12 results in focus

Go toTop